Dolutegravir (Tivicay, Triumeq) and Ketamine Therapy | Tovani Health
Tivicay (Dolutegravir) (also: Triumeq, Dovato, Juluca) — Integrase strand transfer inhibitor (INSTI, HIV treatment)
Verdict at Tovani Health
Fully compatible with KAP.
Dolutegravir and ketamine have no clinically significant interaction. Backbone of many modern HIV single-tablet regimens (Triumeq, Dovato, Juluca) and standalone (Tivicay). Same clean interaction profile as bictegravir.
If you take Tivicay regularly and are considering at-home ketamine therapy, the combination is generally safe at therapeutic doses. This page covers the brief pharmacologic context and what we do at intake.
How Tivicay interacts with ketamine
Dolutegravir inhibits HIV integrase. UGT1A1 substrate; minimal CYP effect.
What we do at intake
Continue as prescribed. Tell us your full HIV regimen.
Bottom line
Dolutegravir and ketamine have no clinically significant interaction. Backbone of many modern HIV single-tablet regimens (Triumeq, Dovato, Juluca) and standalone (Tivicay). Same clean interaction profile as bictegravir.
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Tivicay (Dolutegravir) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 19, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.